Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
暂无分享,去创建一个
Mario Pazzagli | Ivan Brandslund | Chiara Di Resta | Francesca Malentacchi | Elvar Theodorsson | Pieter Vermeersch | I. Brandslund | G. Siest | C. Di Resta | M. Schwab | P. Vermeersch | R. V. van Schaik | M. Pazzagli | J. Marc | E. Theodorsson | I. Mancini | Matthias Schwab | Ron H.N. van Schaik | Janja Marc | Irene Mancini | Gerard Siest | on behalf of the European Federation of Clinical C | F. Malentacchi
[1] Denis Horgan,et al. An Index of Barriers for the Implementation of Personalised Medicine and Pharmacogenomics in Europe , 2014, Public Health Genomics.
[2] Urs A Meyer,et al. Omics and drug response. , 2013, Annual review of pharmacology and toxicology.
[3] R. Sitnik,et al. Personalized medicine and the clinical laboratory , 2014, Einstein.
[4] G. Siest,et al. The theory of reference values: an unfinished symphony , 2013, Clinical chemistry and laboratory medicine.
[5] Xavier Bossuyt,et al. Laboratory medicine: challenges and opportunities. , 2007, Clinical chemistry.
[6] G. Siest,et al. Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. , 1998, Clinical chemistry.
[7] A. Terzic,et al. Policies to aid the adoption of personalized medicine , 2014, Nature Reviews Drug Discovery.
[8] Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. , 2010, American journal of clinical pathology.
[9] William B. Bean,et al. Biochemical Individuality: The Basis for the Genetotrophic Concept. , 1957 .
[10] G. Pravettoni,et al. Personalised medicine: the cognitive side of patients. , 2014, European journal of internal medicine.
[11] Yvan Devaux,et al. miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine? , 2014, Trends in molecular medicine.
[12] G. Siest,et al. Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[13] Olga Golubnitschaja,et al. Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper , 2014, EPMA Journal.
[14] Jason Y. Park,et al. The future of laboratory medicine - a 2014 perspective. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[15] H. Lemke,et al. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘Horizon 2020’ , 2014, EPMA Journal.
[16] B. Melichar. The highs and lows of tumor biomarkers: lost illusions , 2015, Clinical chemistry and laboratory medicine.
[17] Pae C. Wu,et al. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine , 2014, Critical reviews in biotechnology.
[18] E. Diamandis,et al. Whole genome sequencing as a diagnostic test: challenges and opportunities. , 2014, Clinical chemistry.
[19] A. Brand,et al. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective. , 2014, Personalized medicine.
[20] Mario Plebani,et al. Personalized (laboratory) medicine: a bridge to the future , 2013, Clinical chemistry and laboratory medicine.
[21] S. Visvikis-Siest,et al. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases , 2005, Clinical chemistry and laboratory medicine.
[22] T. Obara,et al. Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists , 2015, Pharmacogenomics and personalized medicine.
[23] O. Gottesman,et al. Implementation and utilization of genetic testing in personalized medicine , 2014, Pharmacogenomics and personalized medicine.
[24] M. Piccart,et al. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] U. Dirnagl,et al. Biomedical research: increasing value, reducing waste , 2014, The Lancet.